semaglutide wine and Alcohol: What's Safe and What to Avoid Semaglutide and Alcohol Use —
Description
Most patients on semaglutide for obesity reach the 2.4 mg maintenance dose

GLP-1 medications are reshaping weight loss treatment

The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease

Injecting too much semaglutide can trigger severe nausea, vomiting, hypoglycemia, and gastrointestinal distress

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.